Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Molecular Cancer|September 14, 2014
MicroRNA-21 inhibits p57Kip2 expression in prostate cancerSweta Mishra, Chun-Lin Lin, Tim H-M Huang, et al.Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|October 16, 2025
Evaluating paclitaxel hypersensitivity reaction rates with cetirizine premedication at a large academic cancer centerEmily Messing, Sweta Mishra, George X Huang, et al.Annals of Hematology|January 3, 2021
Krüppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbiditiesRavindra Kumar, Rajiv Yadav, Sweta Mishra, et al.Tropical Medicine & International Health : TM & IH|October 31, 2012
Emergence of a new focus of Plasmodium malariae in forest villages of district Balaghat, Central India: implications for the diagnosis of malaria and its controlPraveen K Bharti, Sunil K Chand, Mrigendra P Singh, et al.Molecular Cancer Research : MCR|August 31, 2013
Inhibition of hedgehog and androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progressionPramod S Gowda, Jianhong D Deng, Sweta Mishra, et al.Plos One|March 9, 2013
Comparative evaluation of bivalent malaria rapid diagnostic tests versus traditional methods in field with special reference to heat stability testing in Central IndiaNeeru Singh, Praveen K Bharti, Mrigendra P Singh, et al.Biochimica Et Biophysica Acta. Gene Regulatory Mechanisms|August 18, 2020
The lysine demethylase KDM4A controls the cell-cycle expression of replicative canonical histone genesCapucine Van Rechem, Fei Ji, Sweta Mishra, et al.Pathogens and Global Health|May 28, 2017
Clinical and molecular monitoring of Plasmodium falciparum resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012-2014Sweta Mishra, Praveen K Bharti, Man M Shukla, et al.The Prostate|February 16, 2011
Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell lineSweta Mishra, Yuping Tang, Long Wang, et al.Oncotarget|November 18, 2015
Estrogen and estrogen receptor alpha promotes malignancy and osteoblastic tumorigenesis in prostate cancerSweta Mishra, Qin Tai, Xiang Gu, et al.Pageof 3